Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine-esketamine-ropivacaine vs Sufentanil-ropivacaine for Epidural Labor Analgesia
NCT07145775Phase 4Completed
- Sponsor
- Peking University First Hospital
- Start
- Sep 2025
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of dexmedetomidine and esketamine in labor pain (3 arms), sponsored by Peking University First Hospital. Primary endpoint: Time-weighted average score of pain intensity during labor. Started Sep 2025; status: completed.
02
Drugs
dexmedetomidineesketamine
03
Conditions
labor pain
Beyond the preview
Go deeper on NCT07145775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07145775.